Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00445315
Status:
COMPLETED
Last Update Posted:
2014-02-17
First Post:
2007-03-06
Brief Title:
A Phase 1 Study Of PF-00868554 In Hepatitis C Virus HCV Positive Patients
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase 1 Randomized Double Blind 3rd Party Open Placebo-controlled Sequential Group Multicentre Study To Evaluate The Multiple Dose Safety Tolerability Pharmacokinetics And Pharmacodynamics of PF-00868554 in Hepatitis C Virus HCV Positive Otherwise Healthy Patient Volunteers
Status:
COMPLETED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Assess the safety tolerability and pharmacokinetics of multiple oral doses of PF-00868554 in HCV positive patient volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None